The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis

<div>Pooled analysis of odds ratio according to reactivity (aspirin: 10066 patients; ADR receptor antagonists: 6750 patients; both: 17436 patients, from above to below in Figure <a href="../fig5/">5</a>).</div>

BioMed Research International

fig5

Figure 5

Figure 5: The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis 

Figure 5 | The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis 